1. Home
  2. EFC vs PLSE Comparison

EFC vs PLSE Comparison

Compare EFC & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFC
  • PLSE
  • Stock Information
  • Founded
  • EFC 2007
  • PLSE 2014
  • Country
  • EFC United States
  • PLSE United States
  • Employees
  • EFC N/A
  • PLSE N/A
  • Industry
  • EFC Real Estate
  • PLSE Medical/Dental Instruments
  • Sector
  • EFC Finance
  • PLSE Health Care
  • Exchange
  • EFC Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • EFC 1.4B
  • PLSE 1.1B
  • IPO Year
  • EFC 2010
  • PLSE 2016
  • Fundamental
  • Price
  • EFC $13.44
  • PLSE $19.69
  • Analyst Decision
  • EFC Strong Buy
  • PLSE Buy
  • Analyst Count
  • EFC 7
  • PLSE 1
  • Target Price
  • EFC $14.46
  • PLSE $22.00
  • AVG Volume (30 Days)
  • EFC 1.6M
  • PLSE 259.9K
  • Earning Date
  • EFC 11-05-2025
  • PLSE 10-29-2025
  • Dividend Yield
  • EFC 11.60%
  • PLSE N/A
  • EPS Growth
  • EFC N/A
  • PLSE N/A
  • EPS
  • EFC 1.24
  • PLSE N/A
  • Revenue
  • EFC $312,485,000.00
  • PLSE N/A
  • Revenue This Year
  • EFC N/A
  • PLSE N/A
  • Revenue Next Year
  • EFC $7.92
  • PLSE $700.00
  • P/E Ratio
  • EFC $10.86
  • PLSE N/A
  • Revenue Growth
  • EFC 10.76
  • PLSE N/A
  • 52 Week Low
  • EFC $11.12
  • PLSE $13.77
  • 52 Week High
  • EFC $14.40
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • EFC 56.21
  • PLSE 70.90
  • Support Level
  • EFC $12.75
  • PLSE $17.10
  • Resistance Level
  • EFC $13.50
  • PLSE $20.40
  • Average True Range (ATR)
  • EFC 0.22
  • PLSE 0.99
  • MACD
  • EFC 0.04
  • PLSE 0.21
  • Stochastic Oscillator
  • EFC 92.67
  • PLSE 81.84

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: